BPA Call 36C24924A0002-36C24926N0017
Award Date 10/1/25
Potential Completion Date 9/30/26
Potential Value $858K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fishers, IN 46037, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA) through its Veterans Health Administration (VHA). The contract, with a ceiling value of $858,000.00, is for the delivery of various radiopharmaceuticals to support the VA's nuclear medicine and medical imaging services for veterans. The contract is a Blanket Purchase Agreement (BPA) call order awarded under a larger $17.5 million BPA the company...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Telix Pharmaceuticals US Inc., a global commercial-stage biopharmaceutical company that manufactures diagnostic and therapeutic radiopharmaceutical products. The $774,700.00 call order is for the supply of various radiopharmaceuticals, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures,...
- Telix Pharmaceuticals US Inc. has been awarded a $479,500 firm fixed price delivery order against a Blanket Purchase Agreement to provide radiopharmaceutical Illuccix for prostate cancer imaging services. The order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 located in Dublin, Ohio, with a completion date of November 6, 2023. As a manufacturer of radiopharmaceutical goods, Telix Pharmaceuticals supports nuclear medicine...
- This is a firm fixed price delivery order awarded to Telix Pharmaceuticals US Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with a ceiling value of $165,000.00. The contract is for the supply of Telix's radiopharmaceutical products, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities across the country. This award is part of Telix's broader contract vehicles with the VA, which include...
- This federal contract award was made by the U.S. Department of Veterans Affairs (VA) to Telix Pharmaceuticals US Inc., a global biopharmaceutical company specializing in radiopharmaceutical products for nuclear medicine and medical imaging. The $1,750,000.00 contract is a Blanket Purchase Agreement (BPA) call order for the supply of the radiopharmaceutical product Illuccix, which is used for prostate cancer imaging. The contract has a firm fixed price pricing type and a performance period ending...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Telix Pharmaceuticals US Inc., a for-profit manufacturer of goods. The $161,700 contract is for the supply of Telix's radiopharmaceutical products, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities through February 2025. This award is part of a larger $17.5 million Blanket Purchase Agreement (BPA) the VA awarded Telix in...
- Telix Pharmaceuticals US Inc. was awarded a $666.8K firm fixed-price delivery order by Veterans Integrated Service Network 22 (VISN 22), a Veterans Affairs entity, for Illuccix PSMA radiopharmaceutical products. The delivery order, issued on February 11, 2025, with an ultimate completion date of February 11, 2026, carries no small business set-aside designation. Performance will occur in Dublin, Ohio. Illuccix is a specialized diagnostic radiopharmaceutical used for prostate cancer imaging in...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded a $637,000 firm fixed price delivery order to Telix Pharmaceuticals US Inc. for ILLUCCIX GA-68 radiopharmaceuticals over a one-year ordering period. The prime contractor Telix Pharmaceuticals will provide radiopharmaceuticals to VA medical facilities located in Fishers, Indiana under the terms of the contract. ILLUCCIX GA-68 is a type of molecular imaging agent used in positron...
- This is a firm fixed price delivery order awarded to Telix Pharmaceuticals US Inc. by the Department of Veterans Affairs (VA) in the amount of $334,300.00. The award is for the delivery of Illuccix, a radiopharmaceutical used for prostate cancer imaging, to support the VA's nuclear medicine and medical imaging services. The award was issued under Telix's existing $17.5 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, as well as the company's other contract...
- Telix Pharmaceuticals US Inc. was awarded a $245,000 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The one-year contract calls for the prime contractor to provide Gozetotide Radiopharmaceuticals to the agency. Telix Pharmaceuticals will perform the work in Norcross, Georgia, providing the specified radiopharmaceutical products to support the...